Journal of Autism and Developmental Disorders

Editorial Preface
pp. 369-371(3)
Authors: Rumsey J.M.; Vitiello B.; Cooper J.; Hirtz D.

Intensive Behavioral/Psychoeducational Treatments for Autism: Research Needs and Future Directions
pp. 373-378(6)
Author: Schreibman L.

Commentary: The Environment as a Source of Variability: Implications for Research with Individuals Who Have Autism
pp. 379-381(3)
Author: Wolery M.

Interventions to Facilitate Communication in Autism
pp. 383-391(9)
Author: Koegel L.K.

Commentary: Achievements and Future Directions for Intervention Research in Communication and Autism Spectrum Disorders
pp. 393-398(6)
Author: Lord C.

Interventions That Facilitate Socialization in Children with Autism
pp. 399-409(11)
Author: Rogers S.J.

Commentary: Interventions to Facilitate Socialization
pp. 411-413(3)
Author: Krantz P.J.

Interventions to Facilitate Auditory, Visual, and Motor Integration in Autism: A Review of the Evidence
pp. 415-421(7)
Authors: Dawson G.; Watling R.

Commentary: Interventions to Facilitate Auditory, Visual, and Motor Integration: “Show Me the Data”
pp. 423-425(3)
Author: Goldstein H.

Repetitive Thoughts and Behavior in Pervasive Developmental Disorders: Treatment with Serotonin Reuptake Inhibitors
pp. 427-435(9)
Authors: McDougle C.J.; Kresch L.E.; Posey D.J.

Commentary: Considerations on the Pharmacological Treatment of Compulsions and Stereotypies with Serotonin Reuptake Inhibitors in Pervasive Developmental Disorders
pp. 437-438(2)
Author: Gordon C.T.

Pharmacological Treatment of Mood Disturbances, Aggression, and Self-Injury in Persons with Pervasive Developmental Disorders
pp. 439-445(7)
Author: King B.H.

Commentary: Considerations on the Characterization and Treatment of Self-Injurious Behavior
pp. 447-450(4)
Author: Ernst M.

Pharmacotherapy for Hyperactivity in Children with Autism and Other Pervasive Developmental Disorders
pp. 451-459(9)
Authors: Aman M.G.; Langworthy K.S.

Commentary: Considerations on the Pharmacotherapy of Attention Deficits and Hyperactivity in Children with Autism and Other Pervasive Developmental Disorders
pp. 461-462(2)
Authors: Nicolson R.; Castellanos F.X.

Metabolic Approaches to the Treatment of Autism Spectrum Disorders
pp. 463-469(7)
Author: Page T.

Commentary: Potential Neurobiologic Mechanisms Through Which Metabolic Disorders Could Relate to Autism
pp. 471-473(3)
Author: Johnston M.V.

Immunological Treatments for Autism
pp. 475-479(5)
Author: Gupta S.

Commentary: Immunological Treatments for Autism: In Search of Reasons for Promising Approaches
pp. 481-484(4)
Author: Zimmerman A.W.

Treatment of Seizure Disorders and EEG Abnormalities in Children with Autism Spectrum Disorders
pp. 485-489(5)
Author: Tuchman R.

Commentary: The Treatment of Seizure Disorders and EEG Abnormalities in Children with Autistic Spectrum Disorders: Are We Getting Ahead of Ourselves?
pp. 491-495(5)
Author: Kanner A.M.

The Basis of Hyperspecificity in Autism: A Preliminary Suggestion Based on Properties of Neural Nets
pp. 497-502(6)
Author: McClelland J.L.

Commentary: A Neural Systems Perspective for Improving Behavioral Treatments for Autism
pp. 503-508(6)
Author: Gordon B.